AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Approval has been granted for a new atypical antipsychotic--Invega (paliperidone) extended-release tablets--for the treatment of schizophrenia. Paliperidone, the principal active metabolite of risperidone, is a new molecular entity containing an active substance that has never been approved…